Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Martin

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Endocrinology|December 7, 2000
A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor IM B Martin, T F Franke, G E Stoica, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymeraseXiao-Ling Cockcroft, Krystyna J Dillon, Lesley Dixon, et al.
The Journal of Biological Chemistry|June 17, 1994
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cellsP Garcia-Morales, M Saceda, N Kenney, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014Kurt G Pike, Karine Malagu, Marc G Hummersone, et al.
Organic & Biomolecular Chemistry|December 4, 2010
Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitorPeter T Sunderland, Archana Dhami, Mary F Mahon, et al.
Journal of Medicinal Chemistry|October 1, 1988
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesisJ B Summers, B P Gunn, J G Martin, et al.
British Journal of Cancer|October 27, 2005
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026B P Nutley, N F Smith, A Hayes, et al.
Cancer Research|December 18, 2004
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATMIan Hickson, Yan Zhao, Caroline J Richardson, et al.
American Journal of Hematology|January 1, 1993
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia majorG M Brittenham, A R Cohen, C E McLaren, et al.
Leukemia|June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutationsA Pardanani, J Hood, T Lasho, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Endocrinology|December 7, 2000
A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor IM B Martin, T F Franke, G E Stoica, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymeraseXiao-Ling Cockcroft, Krystyna J Dillon, Lesley Dixon, et al.
The Journal of Biological Chemistry|June 17, 1994
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cellsP Garcia-Morales, M Saceda, N Kenney, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014Kurt G Pike, Karine Malagu, Marc G Hummersone, et al.
Organic & Biomolecular Chemistry|December 4, 2010
Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitorPeter T Sunderland, Archana Dhami, Mary F Mahon, et al.
Journal of Medicinal Chemistry|October 1, 1988
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesisJ B Summers, B P Gunn, J G Martin, et al.
British Journal of Cancer|October 27, 2005
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026B P Nutley, N F Smith, A Hayes, et al.
Cancer Research|December 18, 2004
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATMIan Hickson, Yan Zhao, Caroline J Richardson, et al.
American Journal of Hematology|January 1, 1993
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia majorG M Brittenham, A R Cohen, C E McLaren, et al.
Leukemia|June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutationsA Pardanani, J Hood, T Lasho, et al.
Pageof 10